News | May 27, 2023
Labindia partners with Hamilton Laboratory to launch ‘Labindia Hamilton’
Product deliveries scheduled in Q3 of 2023
Product deliveries scheduled in Q3 of 2023
Unani Medicine facilities to be upgraded at Hyderabad, Chennai, Lucknow, Silchar and Bengaluru
The Global Medical Countermeasures Platform will provide equal access safe, high-quality, cost-effective medical countermeasures to the world
This is the second US FDA GMP inspection of this facility within one year
India’s efforts are aimed at boosting health at the last mile
The USFDA had classified Strides Puducherry facility as OAI in May 2019 followed by issuing a warning letter to this site in July 2019.
First clinical trial reporting results of an mRNA therapeutic for intracellular protein replacement
These initiatives aim to improve access to healthcare for rare disease patients
The company has reported total income of Rs. 580.81 crores during the period ended March 31, 2023
The Niti Aayog and the DoP had listed a few factors that were leading to a 10-15% disability factor to be globally competitive
Subscribe To Our Newsletter & Stay Updated
